Glaucoma eye drops make you cry or dry: And here's why.
Published In: Medicine Today, 2025, v. 26, n. 11. P. 45 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: AGNIHOTRI, KRITI; DURAI, VIJAY REENA; CORONEO, MINAS T. 3 of 3
Abstract
The article focuses on the relationship between glaucoma treatment and ocular surface disease (OSD), highlighting that up to 60% of glaucoma patients may experience OSD due to the side effects of eye drop medications. It emphasizes the significant impact of OSD on patients' quality of life and treatment adherence, often leading to vision loss. The article outlines the critical role of general practitioners (GPs) in identifying and managing OSD, as well as the importance of collaboration among healthcare providers to optimize patient care. It also details various management strategies for OSD, including the use of preservative-free lubricants and alternative glaucoma medications, while stressing the need for ongoing communication between GPs and ophthalmologists. [Extracted from the article]
Additional Information
- Source:Medicine Today. 2025/11, Vol. 26, Issue 11, p45
- Document Type:Article
- Subject Area:Complementary and Alternative Medicine
- Publication Date:2025
- ISSN:1443-430X
- Accession Number:190172210
- Copyright Statement:Copyright of Medicine Today is the property of Medicine Today Pty Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.